Proactive Infliximab Monitoring Best Sustains Disease Control

Proactive therapeutic drug monitoring with maintenance infliximab proved more effective in sustaining disease control than did standard care in patients with immune-mediated inflammatory diseases.
Medscape Medical News

source https://www.medscape.com/viewarticle/965244?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost